Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.

Auteurs Ohanna M, Cerezo M, Nottet N, Bille K, Didier R, Beranger G, Mograbi B, Rocchi S, Yvan-Charvet L, Ballotti R, Bertolotto C

Genes & development Mar 2018

The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways.

Auteurs Ruggiero C, Doghman-Bouguerra M, Ronco C, Benhida R, Rocchi S, Lalli E

Molecular and cellular endocrinology Fév 2018

Implication of REDD1 in the activation of inflammatory pathways.

Auteurs Pastor F, Dumas K, Barthélémy MA, Regazzetti C, Druelle N, Peraldi P, Cormont M, Tanti JF, Giorgetti-Peraldi S

Scientific reports Août 2017

Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3.

Auteurs Regazzetti C, Sormani L, Debayle D, Bernerd F, Tulic MK, De Donatis GM, Chignon-Sicard B, Rocchi S, Passeron T

The Journal of investigative dermatology Août 2017

The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells.

Auteurs Loubiere C, Clavel S, Gilleron J, Harisseh R, Fauconnier J, Ben-Sahra I, Kaminski L, Laurent K, Herkenne S, Lacas-Gervais S, Ambrosetti D, Alcor D, Rocchi S, Cormont M, Michiels JF, Mari B, Mazure NM, Scorrano L, Lacampagne A, Gharib A, Tanti JF, Bost F

Scientific reports Juil 2017

Focus on cutaneous and uveal melanoma specificities.

Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C

Genes & development May 2017

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.

Auteurs Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M, Bille K, Hofman V, Bossis G, Marco de Donatis G, Strub T, Cheli Y, Ohanna M, Luciano F, Marchetti S, Rocchi S, Birling MC, Avril MF, Poulalhon N, Luc T, Hofman P, Lacour JP, Davidson I, Bressac-de Paillerets B, Ballotti R, Marine JC, Bertolotto C

Journal of the National Cancer Institute Apr 2017

Structure activity relationship and optimization of N-(3-(2-aminothiazol-4-yl)aryl)benzenesulfonamides as anti-cancer compounds against sensitive and resistant cells.

Auteurs Ronco C, Millet A, Plaisant M, Abbe P, Hamouda-Tekaya N, Rocchi S, Benhida R

Bioorganic & medicinal chemistry letters Mar 2017

Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death.

Auteurs Cerezo M, Benhida R, Rocchi S

Oncoscience Déc 2016

Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.

Auteurs Baird AC, Mallon D, Radford-Smith G, Boyer J, Piche T, Prescott SL, Lawrance IC, Tulic MK

World journal of gastroenterology Nov 2016